Approval · Notice of Compliance 19140 · 2017
PEMETREXED: Notice of Compliance 19140
Issued April 6, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19140
- Date
- April 6, 2017
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revisions to the labels
- Canadian reference product
- ALIMTA (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEMETREXED | Not yet assigned | — |
Medicinal ingredients
- PEMETREXED DISODIUM 100 MG per VIAL
- PEMETREXED DISODIUM 500 MG per VIAL